2Kantor PF, Lucien A, Kozak K, et al. The antianginal drug tfimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial longchain - 3 - keetoacyl coenzyme A thiolase[J] .Circ Res, 2000,86:580 - 588. 被引量：1
3Allibardi S, Chierchia SL, Margonato V, et al. Effects of trimetazidine on metabolic and functional recovery of postischemic rat heart[ J ]. Cardiovasc Drugs Ther, 1998,12(6) :543 - 549. 被引量：1
4Jackson G.The place of metabolic agents in the management of stable angina oectoris[J] . Rev Port Cardiol, 1999, 18(Suool 4) : I23 - 27. 被引量：1
5Kantor PF, Lucien A, Kozak K, et al. The antianginal drug trimetazidine shifts cardiac energy metabolisn from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial longchain - 3 - keetoacyl coenzyme A thiolase[J] .Circ Res,2000,86:580- 588 被引量：1
6Allibardi S, Chierchia SL, Margonato V, et al.Effects of trimetazidine on metabolic and functional recovery of postischemic mt heart[ J]. Cardiovasc Drugs Ther, 1998,12(6) :543 - 549. 被引量：1
7Jackson G.The place of metabolic agents in the management of stable angina pectoris[J] .Rev Port Cardiol, 1999,18(Subpl 4) : 123 - 27. 被引量：1
